Chlorhexidine
gluconate (CHG) has been increasingly used in hospitals in light of recent
evidence that daily antiseptic baths for patients in intensive care units
(ICUs) may prevent infections and stop the spread of healthcare-associated
infections. However, the impact of this expanded use on the effectiveness of
the disinfectant is not yet known.
In
a recent study, investigators compared bacterial resistance between cultures
from patients in eight ICUs receiving daily antiseptic washes to patients in 30
non-ICUs who did not bathe daily with CHG. Bacterial cultures obtained from
patients with regular antiseptic baths showed reduced susceptibility to CHG
when compared with those from patients who did not have antiseptic baths.
Regardless of unit protocol, 69 percent of all bacteria showed reduced CHG
susceptibility, a trend that requires vigilant monitoring.
The
investigators caution that the clinical implications of their findings remain
unclear. For example, antibiotic susceptibility tests are commonly used to
determine whether patients will respond to antibiotic treatment. A similar
correlation between antiseptic susceptibility and response to an antiseptic are
not as well defined. Identifying particular bacteria and settings in which
these bacteria will not respond to antiseptic agents used in hospitals is an
important next step.
The
reference is:
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources